Crijns H J, Wiesfeld A C, Posma J L, Lie K I
Department of Cardiology, University Hospital Groningen, The Netherlands.
Br Heart J. 1995 Oct;74(4):408-12. doi: 10.1136/hrt.74.4.408.
In the absence of an obvious cause for cardiac arrest, patients with idiopathic ventricular fibrillation are difficult to manage. A subset of patients has inducible arrhythmias. In others sympathetic excitation plays a role in the onset of the cardiac arrest. This study evaluates a prospective stepped care approach in the management of idiopathic ventricular fibrillation, with therapy first directed at induced arrhythmias and secondly at adrenergic trigger events.
University Hospital.
10 consecutive patients successfully resuscitated from idiopathic ventricular fibrillation.
Programmed electrical stimulation to determine inducibility, followed by serial drug treatment. Assessment of pre-arrest physical activity and mental stress status by interview, followed by beta blockade. Cardioverter-defibrillator implantation in non-inducible patients not showing significant arrest related sympathetic excitation.
Recurrent cardiac arrest or ventricular tachycardia.
Five patients were managed with serial drug treatment and four with beta blockade. In one patient a defibrillator was implanted. During a median follow up of 2.8 years (range 6 to 112 months) no patient died or experienced defibrillator shocks. One patient had a recurrence of a well tolerated ventricular tachycardia on disopyramide.
Idiopathic ventricular fibrillation may be related to enhanced sympathetic activation. Prognosis may be favourable irrespective of the method of treatment. Whether the present approach enhances prognosis of idiopathic ventricular fibrillation remains to be determined. However, it may help to avoid potentially hazardous antiarrhythmic drugs or obviate the need for implantation of cardioverter-defibrillators.
在没有明显心脏骤停原因的情况下,特发性室颤患者难以管理。一部分患者可诱发出心律失常。其他患者中,交感神经兴奋在心脏骤停发作中起作用。本研究评估一种前瞻性分步治疗方法用于特发性室颤的管理,治疗首先针对诱发性心律失常,其次针对肾上腺素能触发事件。
大学医院。
10例连续从特发性室颤成功复苏的患者。
进行程序性电刺激以确定可诱导性,随后进行系列药物治疗。通过访谈评估心脏骤停前的体力活动和精神应激状态,随后进行β受体阻滞剂治疗。对未显示出与心脏骤停相关的明显交感神经兴奋的不可诱导患者植入心脏转复除颤器。
复发性心脏骤停或室性心动过速。
5例患者接受系列药物治疗,4例接受β受体阻滞剂治疗。1例患者植入了除颤器。在中位随访时间2.8年(范围6至112个月)内,无患者死亡或接受除颤器电击。1例患者在服用丙吡胺时出现耐受性良好的室性心动过速复发。
特发性室颤可能与交感神经激活增强有关。无论治疗方法如何,预后可能良好。目前的方法是否能改善特发性室颤的预后仍有待确定。然而,它可能有助于避免潜在有害的抗心律失常药物或消除植入心脏转复除颤器的必要性。